Merck’s Blockbuster Cancer Treatment Powers Profit

(Bloomberg) -- Merck & Co.’s blockbuster Keytruda is dominating the cancer market, but investors want to know what the drugmaker plans for its next act.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.